Join
Live feed
·
PRReleasevia Quantisnow
Novartis AG logo
Voyager Therapeutics Inc. logo

Voyager Therapeutics Announces License Option Agreement with Novartis for Target-Specific Access to Next-Generation TRACER™ AAV Capsids for Gene Therapy Programs

ByQuantisnow·Wall Street's wire, on your screen.
NVS· Novartis AGVYGR· Voyager Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NVS (Novartis AG), VYGR (Voyager Therapeutics Inc.) and more on Quantisnow.